Minister MacAulay appoints new commissioner of the Canadian Dairy Commission

Jan 05, 2017

Jennifer Hayes received the appointment on January 3

By Diego Flammini
Assistant Editor, North American Content
Farms.com

The Canadian Dairy Commission (CDC) has a new commissioner and her name is Jennifer Hayes.

Minister of Agriculture Lawrence MacAulay appointed Hayes to the three-year-long position on January 3.

"I am pleased to announce the appointment of Jennifer Hayes to the Canadian Dairy Commission,” Minister MacAulay said in a release. “Jennifer's energy, talent and commitment to the Canadian dairy industry will be an asset to the Commission and her leadership and experience can serve as a model to young women considering a career in agriculture."

As commissioner of the CDC, Hayes will help “provide efficient producers of milk and cream with the opportunity to obtain a fair return for their labour and investment, and provide consumers of dairy products with a continuous and adequate supply of dairy products of high quality.”

Dairy Farmers of Canada expressed its congratulations to Ms. Hayes on Twitter.

About Jennifer Hayes

A dairy and beef farmer on Quebec’s Gaspe Peninsula at PineCrest Farms in Shigawake,
Holds an MBA from Concordia University,
Since 2012 has acted as a Revitalization Agent at the MRC of Bonaventure where she’d helped rural municipalities formalize social and economic development plans, and
A skilled partnership broker incorporating partners from the private sector and multiple government agencies at different levels.

Jennifer is very active on social media can be followed on Twitter at @FarmShigawake.

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.